Back
Amicus Therapeutics, Inc. Stock Price Chart
1.5 Million Users. Zero Hype. Still Private.
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Buy
69
FOLD
Amicus Therapeutics, Inc.
Last Price:
$14.29
Seasonality Move:
-8.49%
7 Day Trial
ALL ACCESS PASS
$
7
Size matters when it's your portfolio.
Invest now at $0.85/share-
The current trend is relatively stagnant and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
Amicus Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.28 | Buy |
| 20-day SMA: | 14.3 | Buy |
| 50-day SMA: | 12.88 | Buy |
| 200-day SMA: | 8.68 | Buy |
| 8-day EMA: | 14.29 | Buy |
| 20-day EMA: | 14.13 | Buy |
| 50-day EMA: | 12.99 | Buy |
| 200-day EMA: | 10.11 | Buy |
Amicus Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 79.35 | Buy |
| Chaikin Money Flow: | 24424770 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.26 - 14.32) | Buy |
| Bollinger Bands (100): | (8.2 - 13.32) | Buy |
Amicus Therapeutics, Inc. Technical Analysis
| Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 26 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics, Inc. Stock
Is Amicus Therapeutics, Inc. Stock a Buy?
-
Amicus Therapeutics, Inc. share price is 14.30 while FOLD 8-day simple moving average is 14.28, which is a Buy signal.
-
The stock price of FOLD is 14.30 while Amicus Therapeutics, Inc. 20-day SMA is 14.30, which makes it a Buy.
-
Amicus Therapeutics, Inc. 50-day simple moving average is 12.88 while FOLD share price is 14.30, making it a Buy technically.
-
FOLD stock price is 14.30 and Amicus Therapeutics, Inc. 200-day simple moving average is 8.68, creating a Buy signal.
FOLD Technical Analysis vs Fundamental Analysis
Buy
69
Amicus Therapeutics, Inc. (FOLD)
is a Buy
Is Amicus Therapeutics, Inc. a Buy or a Sell?
-
Amicus Therapeutics, Inc. stock is rated a BuyThe current Amicus Therapeutics, Inc. [FOLD] share price is $14.30. The Score for FOLD is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Amicus Therapeutics, Inc. Stock Info
Market Cap:
4.4B
Price in USD:
14.30
Share Volume:
24.4M
Amicus Therapeutics, Inc. 52-Week Range
52-Week High:
14.38
52-Week Low:
5.51
Buy
69
Amicus Therapeutics, Inc. (FOLD)
is a Buy
Amicus Therapeutics, Inc. Share Price Forecast
-
What is the Amicus Therapeutics, Inc. stock price today?The Amicus Therapeutics, Inc. stock price is 14.30 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics, Inc. is not overvalued.
Is Amicus Therapeutics, Inc. Stock a Buy?
-
Amicus Therapeutics, Inc. share price is 14.30 while FOLD 8-day exponential moving average is 14.29, which is a Buy signal.
-
The stock price of FOLD is 14.30 while Amicus Therapeutics, Inc. 20-day EMA is 14.13, which makes it a Buy.
-
Amicus Therapeutics, Inc. 50-day exponential moving average is 12.99 while FOLD share price is 14.30, making it a Buy technically.
-
FOLD stock price is 14.30 and Amicus Therapeutics, Inc. 200-day simple moving average is 10.11, creating a Buy signal.
Fundamental Analysis of Amicus Therapeutics, Inc.
Is Amicus Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.27 per share.
Technical Analysis of Amicus Therapeutics, Inc.
Should I short Amicus Therapeutics, Inc. stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Amicus Therapeutics, Inc. is a Buy
-
Amicus Therapeutics, Inc. Relative Strength Index (RSI) is 79.35, which suggest Amicus Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Amicus Therapeutics, Inc. is (14.26 - 14.32), which suggest Amicus Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Amicus Therapeutics, Inc. is (8.2 - 13.32), which suggest Amicus Therapeutics, Inc. is a Buy
* Amicus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.